Lista de obras -

Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.

artículo científico publicado en 2017

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis

artículo científico publicado en 2023

Are increased fetal movements always reassuring?

scientific article published on 22 February 2019

Chorioamnionitis Occurring in Women With Preterm Rupture of the Fetal Membranes Is Associated With a Dynamic Increase in mRNAs Coding Cytokines in the Maternal Circulation

artículo científico publicado en 2015

Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero

artículo científico publicado en 2013

Clinical care of pregnant and postpartum women with COVID-19: Living recommendations from the National COVID-19 Clinical Evidence Taskforce

artículo científico publicado en 2020

EGFL7 gene expression is regulated by hypoxia in trophoblast and altered in the plasma of patients with early preeclampsia

artículo científico publicado en 2018

Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growth

artículo científico publicado en 2013

Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.

artículo científico publicado en 2015

Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.

artículo científico publicado en 2016

MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.

artículo científico publicado en 2012

Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restriction

artículo científico publicado en 2013

Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status

artículo científico publicado en 2013

Quantifying mRNA coding growth genes in the maternal circulation to detect fetal growth restriction

artículo científico publicado en 2013

Risk of recurrent shoulder dystocia: are we any closer to prediction?

artículo científico publicado en 2018

Serum concentrations of soluble Flt-1 are decreased among women with a viable fetus and no symptoms of miscarriage destined for pregnancy loss

artículo científico publicado en 2012

Steroid sulfatase is increased in the placentas and whole blood of women with early-onset preeclampsia

artículo científico publicado en 2016

Treatment of early-onset preeclampsia with continuous positive airway pressure

artículo científico publicado en 2015

Lista de obras de

Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis

Are increased fetal movements always reassuring?

Chorioamnionitis Occurring in Women With Preterm Rupture of the Fetal Membranes Is Associated With a Dynamic Increase in mRNAs Coding Cytokines in the Maternal Circulation

Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero

Clinical care of pregnant and postpartum women with COVID-19: Living recommendations from the National COVID-19 Clinical Evidence Taskforce

EGFL7 gene expression is regulated by hypoxia in trophoblast and altered in the plasma of patients with early preeclampsia

Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growth

Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.

Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.

MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.

Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restriction

Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status

Quantifying mRNA coding growth genes in the maternal circulation to detect fetal growth restriction

Risk of recurrent shoulder dystocia: are we any closer to prediction?

Serum concentrations of soluble Flt-1 are decreased among women with a viable fetus and no symptoms of miscarriage destined for pregnancy loss

Steroid sulfatase is increased in the placentas and whole blood of women with early-onset preeclampsia

Treatment of early-onset preeclampsia with continuous positive airway pressure